Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Evogen Announces The Launch Of High Sensitivity Molecular Diagnostics And Detection Instrument

Evogen, Inc. has announced the launch of its novel molecular diagnostics and detection instrument providing innovative ultra-rapid PCR amplification and analysis. The compact EvoCycler HD12 is significantly more affordable than comparable instruments with numerous performance advantages. In conjunction with the highly sensitive and specific HyBeacons PCR chemistry, recently licensed from LGC, Ltd., Evogen offers the next evolution in High Definition PCR. The EvoCycler HD12 is an innovative instrument that combines ultra-rapid amplification together with detection within a single integrated platform. Designed for clinical, research, environmental and biodefense applications, the EvoCycler HD12 can process 12 samples in 30 minutes. The operator-intuitive instrument software automates key tasks, from selection of the most appropriate primers and thermal cycling conditions through to auto-calling of results. “The EvoCycler HD12 was developed with careful consideration of the broad range of needs of our customers, ranging from highly skilled molecular biologists to users operating with only limited training and supervision,” said Sean Reineke, Evogen’s President and CEO. “The combination of this remarkable instrument and the proprietary HyBeacon chemistry provides superior performance quickly and easily. Additionally, the EvoCycler HD12 is extremely affordable so that we can deliver personal, intelligent molecular diagnostics into all settings. Evogen is one of the few companies with both a molecular diagnostic instrument platform as well as chemistry, giving us a unique advantage and ability to develop cost-effective tailored solutions to meet specific customer requirements in a range of target markets. Evogen is now focused on establishing relationships with content providers and market channel providers, allowing us to rapidly expand our menu offerings and enable our partners to have unique competitive advantage.”